4.2 Article

Evaluation Criteria for Musculoskeletal and Craniofacial Tissue Engineering Constructs: A Conference Report

期刊

TISSUE ENGINEERING PART A
卷 14, 期 12, 页码 2089-2104

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/ten.tea.2007.0383

关键词

-

资金

  1. National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS], National Institute of Biomedical Imaging and Bioengineering [NIBIB], and National Institute of Dental and Craniofacial Research [NIDCR]) [R13AR54721-1]
  2. Orthopaedic Research and Education Foundation
  3. Orthopaedic Research Society
  4. Bose Corporation
  5. Flexcell International Corporation
  6. LifeCell Corporation
  7. Johnson & Johnson Regenerative Therapeutics
  8. Smith Nephew
  9. Stryker Orthopedics Corporation
  10. Synthasome, Inc.

向作者/读者索取更多资源

Over the past 20 years, tissue engineering (TE) has evolved into a thriving research and commercial development field. However, applying TE strategies to musculoskeletal (MSK) and craniofacial tissues has been particularly challenging since these tissues must also transmit loads during activities of daily living. To address this need, organizers invited a small group of bioengineers, surgeons, biologists, and material scientists from academia, industry, and government to participate in a 2 1/2-day conference to develop general and tissue-specific criteria for evaluating new concepts and tissue-engineered constructs, including threshold values of success. Participants were assigned to four breakout groups representing commonly injured tissues, including tendon and ligament, articular cartilage, meniscus and temporomandibular joint, and bone and intervertebral disc. Working in multidisciplinary teams, participants first carefully defined one or two important unmet clinical needs for each tissue type, including current standards of care and the potential impact of TE solutions. The groups then sought to identify important parameters for evaluating repair outcomes in preclinical studies and to specify minimally acceptable values for these parameters. The importance of in vitro TE studies was then discussed in the context of these preclinical studies. Where data were not currently available from clinical, preclinical, or culture studies, the groups sought to identify important areas of preclinical research needed to speed the development process. This report summarizes the findings of the conference.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据